Skip to main content
SpringerLink
Log in
Book cover

Measurements in Wound Healing pp 39–61Cite as

Atypical Ulcers

  • Chapter
  • First Online:

Abstract

Atypical wounds are those that are not of pressure, venous, diabetic, or arterial etiology. They are encountered infrequently and less well studied. Wounds should be evaluated for atypical etiology if present on a location deviating from that of a common chronic wound, appears different than a common chronic wound, has unusual symptoms such as out of proportion pain or does not respond to conventional therapy. We present methods to diagnose and monitor wound progress. The focus is diagnostic measures such as hematoxylin and eosin staining, immunohistochemical stains, immunofluorescence, microbiology culture, and polymerase chain reaction. The utilization of these measurement tools is evaluated for various types of atypical wounds. Wounds arising from inflammatory causes, infectious causes, vasculopathies, metabolic disorders, malignancies, external causes, drug-induced causes, and epidermolysis bullosa are explored. Wound measurement enables appropriate treatment in the care of atypical ulcers to enhance healing, decrease morbidity, and reduce the healthcare burden overall.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Coon WW, Willis 3rd PW, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. 1973;48(4):839–46.

    Article  PubMed  CAS  Google Scholar 

  2. Srinivasaiah N, Dugdall H, Barrett S, et al. A point prevalence survey of wounds in North-East England. J Wound Care. 2007;16(10):413–6. 18–9.

    PubMed  CAS  Google Scholar 

  3. Patel GK, Grey JE, Harding KG. Uncommon causes of ulceration. BMJ. 2006;332(7541):594–6.

    Article  PubMed  Google Scholar 

  4. Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology. 2010;56(1):3–23.

    Article  PubMed  Google Scholar 

  5. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9(2):71–92.

    Article  PubMed  Google Scholar 

  6. Lapraik C, Watts R, Scott DG. Modern management of primary systemic vasculitis. Clin Med. 2007;7(1):43–7.

    PubMed  Google Scholar 

  7. Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am. 2007;33(4):787–802. vi.

    Article  PubMed  Google Scholar 

  8. Bennett ML, Jackson JM, Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79(1):37–46.

    Article  CAS  Google Scholar 

  9. Ruocco E, Sangiuliano S, Gravina AG, et al. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009;23(9):1008–17.

    Article  PubMed  CAS  Google Scholar 

  10. Geren S, Kerdel F, Falabella A, et al. Infliximab: a treatment option for ulcerative pyoderma gangrenosum. Wounds. 2003;15(2):49–53.

    Google Scholar 

  11. Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol. 2007;57(3):413–20.

    Article  PubMed  Google Scholar 

  12. Kwyer TA, Ampadu E. Buruli ulcers: an emerging health problem in Ghana. Adv Skin Wound Care. 2006;19(9):479–86.

    Article  PubMed  Google Scholar 

  13. Nienhuis WA, Stienstra Y, Thompson WA, et al. Antimicrobial treatment for early, limited mycobacterium ulcerans infection: a randomised controlled trial. Lancet. 2010;375(9715):664–72.

    Article  PubMed  CAS  Google Scholar 

  14. Ampadu E, Kwyer TA, Otcher Y. Buruli ulcer: picture of an emerging health challenge and the response in Ghana. JWCET. 2006;26(4):30–6.

    Google Scholar 

  15. Ramos-e-Silva M, Vasconcelos C, Carneiro S, et al. Sporotrichosis. Clin Dermatol. 2007;25(2):181–7.

    Article  PubMed  Google Scholar 

  16. Lopez Martinez R, Mendez Tovar LJ. Chromoblastomycosis. Clin Dermatol. 2007;25(2):188–94.

    Article  PubMed  Google Scholar 

  17. Negroni R, Tobon A, Bustamante B, et al. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo. 2005;47(6):339–46.

    Article  PubMed  Google Scholar 

  18. Ameen M. Managing chromoblastomycosis. Trop Doct. 2010;40(2):65–7.

    Article  PubMed  Google Scholar 

  19. Ramos ESM, Saraiva Ldo E. Paracoccidioidomycosis. Dermatol Clin. 2008;26(2):257–69. vii.

    Article  Google Scholar 

  20. Lichon V, Khachemoune A. Mycetoma: a review. Am J Clin Dermatol. 2006;7(5):315–21.

    Article  PubMed  Google Scholar 

  21. Fahal AH, Sheik HE, Homeida MM, et al. Ultrasonographic imaging of mycetoma. Br J Surg. 1997;84(8):1120–2.

    Article  PubMed  CAS  Google Scholar 

  22. Ameen M, Arenas R. Developments in the management of mycetomas. Clin Exp Dermatol. 2009;34(1):1–7.

    Article  PubMed  CAS  Google Scholar 

  23. Bross MH, Soch K, Morales R, et al. Vibrio vulnificus infection: diagnosis and treatment. Am Fam Physician. 2007;76(4):539–44.

    PubMed  Google Scholar 

  24. Salcido RS. Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care. 2007;20(5):288–93; quiz 94–5.

    Article  PubMed  Google Scholar 

  25. McHenry CR, Piotrowski JJ, Petrinic D, et al. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg. 1995;221(5):558–63; discussion 63–5.

    Article  PubMed  CAS  Google Scholar 

  26. Ogilvie CM, Miclau T. Necrotizing soft tissue infections of the extremities and back. Clin Orthop Relat Res. 2006;447:179–86.

    Article  PubMed  Google Scholar 

  27. Unalp HR, Kamer E, Derici H, et al. Fournier’s gangrene: evaluation of 68 patients and analysis of prognostic variables. J Postgrad Med. 2008;54(2):102–5.

    Article  PubMed  CAS  Google Scholar 

  28. Angoules AG, Kontakis G, Drakoulakis E, et al. Necrotising fasciitis of upper and lower limb: a systematic review. Injury. 2007;38 Suppl 5:S19–26.

    PubMed  Google Scholar 

  29. Falanga V, Kirsner RS, Eaglstein WH, et al. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet. 1991;338(8763):347–8.

    Article  PubMed  CAS  Google Scholar 

  30. Tedeschi A, Barate C, Minola E, et al. Cryoglobulinemia. Blood Rev. 2007;21(4):183–200.

    Article  PubMed  CAS  Google Scholar 

  31. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis. 2008;3:25.

    Article  PubMed  Google Scholar 

  32. Iannuzzella F, Vaglio A, Garini G. Management of hepatitis C virus-related mixed cryoglobulinemia. Am J Med. 2010;123(5):400–8.

    Article  PubMed  Google Scholar 

  33. Eby C. Antiphospholipid syndrome review. Clin Lab Med. 2009;29(2):305–19.

    Article  PubMed  Google Scholar 

  34. Lim W. Antiphospholipid antibody syndrome. Hematology Am Soc Hematol Educ Prog. 2009;1:233–9.

    Google Scholar 

  35. Budisavljevic MN, Cheek D, Ploth DW. Calciphylaxis in chronic renal failure. J Am Soc Nephrol. 1996;7(7):978–82.

    PubMed  CAS  Google Scholar 

  36. Angelis M, Wong LL, Myers SA, et al. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery. 1997;122(6):1083–9; discussion 89–90.

    Article  PubMed  CAS  Google Scholar 

  37. Dauden E, Onate MJ. Calciphylaxis. Dermatol Clin. 2008;26(4):557–68. ix.

    Article  PubMed  Google Scholar 

  38. Guldbakke KK, Khachemoune A. Calciphylaxis. Int J Dermatol. 2007;46(3):231–8.

    Article  PubMed  CAS  Google Scholar 

  39. Weenig RH, Sewell LD, Davis MD, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569–79.

    Article  PubMed  Google Scholar 

  40. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 2002;61(6):2210–7.

    Article  PubMed  Google Scholar 

  41. Rogers NM, Coates PT. Calcific uraemic arteriolopathy: an update. Curr Opin Nephrol Hypertens. 2008;17(6):629–34.

    Article  PubMed  Google Scholar 

  42. Weenig RH. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol. 2008;58(3):458–71.

    Article  PubMed  Google Scholar 

  43. Yang D, Morrison BD, Vandongen YK, et al. Malignancy in chronic leg ulcers. Med J Aust. 1996;164(12):718–20.

    PubMed  CAS  Google Scholar 

  44. Chang A, Spencer JM, Kirsner RS. Squamous cell carcinoma arising from a nonhealing wound and osteomyelitis treated with Mohs micrographic surgery: a case study. Ostomy Wound Manage. 1998;44(4):26–30.

    PubMed  CAS  Google Scholar 

  45. Copcu E. Marjolin’s ulcer: a preventable complication of burns? Plast Reconstr Surg. 2009;124(1):156e–6464.

    Article  PubMed  CAS  Google Scholar 

  46. Hogan CJ, Barbaro KC, Winkel K. Loxoscelism: old obstacles, new directions. Ann Emerg Med. 2004;44(6):608–24.

    Article  PubMed  Google Scholar 

  47. Bates N. Acid and alkali injury. Emerg Nurse. 1999;7(8):21–6.

    PubMed  CAS  Google Scholar 

  48. Newcomer VD, Young Jr EM. Unique wounds and wound emergencies. Dermatol Clin. 1993;11(4):715–27.

    PubMed  CAS  Google Scholar 

  49. Nazarian RM, Van Cott EM, Zembowicz A, et al. Warfarin-induced skin necrosis. J Am Acad Dermatol. 2009;61(2):325–32.

    Article  PubMed  Google Scholar 

  50. Doellman D, Hadaway L, Bowe-Geddes LA, et al. Infiltration and extravasation: update on prevention and management. J Infus Nurs. 2009;32(4):203–11.

    Article  PubMed  Google Scholar 

  51. Fine JD, Bauer EA, McGuire J, Moshell A, editors. Epidermolysis bullosa: clinical, epidemiologic, and laboratory advances and the findings of the national epidermolysis bullosa registry. Baltimore: Johns Hopkins University Press; 1999.

    Google Scholar 

  52. Wright JT, Fine JD, Johnson LB. Oral soft tissues in hereditary epidermolysis bullosa. Oral Surg Oral Med Oral Pathol. 1991;71:440–6.

    Article  PubMed  CAS  Google Scholar 

  53. Hintner H, Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol. 1982;118:375–84.

    Article  PubMed  CAS  Google Scholar 

  54. Fine JD, Johnson LB, Weiner M, et al. Eye involvement in inherited epidermolysis bullosa (EB): experience of the national EB registry. Am J Ophthalmol. 2004;138:254–62.

    Article  PubMed  Google Scholar 

  55. Fine JD, Johnson LB, Weiner M, Suchindran C. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the national EB registry. J Pediatr Gastroenterol Nutr. 2008;46:146–58.

    Google Scholar 

  56. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, McGrath JA, Mellerio JE, Murrell DF, Shimizu H, Uitto J, Vahlquist A, Woodley D, Zambruno G. The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol. 2008;58(6):931–50.

    Article  PubMed  Google Scholar 

  57. Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010;5:12.

    Article  PubMed  Google Scholar 

  58. Fine JD, Smith LT. Non-molecular diagnostic testing of inherited epidermolysis bullosa: current techniques, major findings, and relative sensitivity and specificity. Baltimore, MD: Johns Hopkins University Press; 1999. p. 48–78.

    Google Scholar 

  59. Buonocore SD, Ariyan S. Cadaveric allograft for wound closure after resection of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a report of 32 resections and repairs in 2 patients. Ann Plast Surg. 2009;63:297–9.

    Article  PubMed  CAS  Google Scholar 

  60. Wong T, Gammon L, Liu L, et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2009;17(1):26–33.

    Article  PubMed  CAS  Google Scholar 

  61. Remington J, Wang X, Hou Y, et al. Injection of recombinant human type VIII collagen corrects the disease phenotype in a murine model of dystrophic epidermalysis bullosa. Mol Ther. 2009;17:26–33.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Miami Miller School of Medicine, Miami, FL, USA

    Jennifer Tang B.S.

  2. Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1600 N.W. 10th Avenue, RMSB, Room 2023-A, Miami, FL, 33136, USA

    Robert S. Kirsner M.D., Ph.D.

Authors
  1. Jennifer Tang B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert S. Kirsner M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert S. Kirsner M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. School of Medicine, University of Southampton, Tremona Road, Southampton, SO16 6YD, United Kingdom

    Raj Mani

  2. Centro SERRA, Università di Pisa, Lungarno Pacinotti 43, Pisa, 56100, Italy

    Marco Romanelli

  3. Banaras Hindu University, Varanasi, New F. Jodhpur Colony 6, Varanasi, 221 005, India

    Vijay Shukla

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Tang, J., Kirsner, R.S. (2012). Atypical Ulcers. In: Mani, R., Romanelli, M., Shukla, V. (eds) Measurements in Wound Healing. Springer, London. https://doi.org/10.1007/978-1-4471-2987-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2987-5_3

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2986-8

  • Online ISBN: 978-1-4471-2987-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation